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Background: We sought to identify factors associated with participant retention in a 2-year, physician-lead,
multidisciplinary, clinical weight management program that employs meal replacements to produce weight loss
and intensive behavioral interventions and financial incentives for weight loss maintenance. We studied 270
participants enrolled in 2010 and 2011. Sociodemographic factors, health insurance, distance traveled, body mass
index, comorbidities, health-related quality-of-life, and depression were explored as potential predictors of retention.
Results: Mean age was 49 ± 8 years and BMI was 41 ± 5 kg/m2. Retention was excellent at 3 months (90%) and
6 months (83%). Attrition was greatest after participants were transitioned to regular foodstuffs and fell to 67% at
12 months and 51% at 2 years. Weight decreased by 15 ± 12 kg and BMI decreased by 5.1 ± 4.0 kg/m2 in 2-year
completers. Older age, lower baseline BMI, and financial incentives for program participation were independently
associated with retention. Fewer depressive symptoms at baseline were associated with retention.
Conclusions: This multidisciplinary, clinical, weight management program demonstrated high retention and
excellent outcomes. Older age at baseline, less extreme obesity, and financial incentives were associated with
program retention.
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Retention is a major challenge for behavioral weight
management programs and directly impacts their effect-
iveness. In a systematic review of major commercial
weight loss programs, Tsai and Wadden concluded that
behavioral programs that employ low-calorie exchange
diets and weekly group sessions can produce 5% weight
loss at 2 years [1]. More recently, Spring and colleagues
described patient retention in a clinical weight manage-
ment program implemented in the Veterans Health
Administration that focuses on diet, physical activity,
and behavior modification [2]. Sixty-four percent of par-
ticipants remained in the program after the first session,
36% remained in the program at ~3 months, and only* Correspondence: arothber@med.umich.edu
1Department of Internal Medicine, University of Michigan, 24 Frank Lloyd
Wright Drive, Ann Arbor, MI 48106, USA
Full list of author information is available at the end of the article
© 2015 Rothberg et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.26% remained in the program at ~6 months [2]. In
multivariate analyses, older veterans, women veterans,
and obese and morbidly obese veterans compared to
overweight veterans were more likely to remain in the
program. Use of incentives or rewards was also associ-
ated with greater retention [2]. More intensive weight
management programs led by physicians and other
health care providers that employ weekly classes, group
sessions, and very low-calorie diets (VLCD) using meal
replacement products have been shown to produce 15%
to 25% weight loss at 3 to 6 months but are associated
with higher attrition and a high probability of ≥50%
weight regain at 1 to 2 years, especially when imple-
mented in real world clinical settings and not as a part
of a randomized controlled clinical trial [1].
The purpose of this study was to describe factors associ-
ated with retention in a 2-year, physician-led, multidiscip-
linary, intensive behavioral weight management programal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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induce weight loss, and intensive behavioral interventions
and financial incentives to facilitate long-term weight
loss maintenance. This program was a self-sustaining
clinical program implemented without the supplemental
resources often available in clinical trials. We hypothesized
that by identifying patient-level factors and clinical out-
comes associated with program retention, we could
modify the program to improve future effectiveness and
efficiency.
Methods
The University of Michigan Weight Management Program
(WMP) is a two-year clinical program that employs inten-
sive energy restriction for the first 3 to 6 months to pro-
mote 15% weight loss, followed by behavioral change and
physical activity counseling to promote longer-term weight
loss maintenance. Prior to enrollment, patients are asked to
review an online orientation session that discusses the
scope of the obesity problem, the biology of obesity, and
the rationale, approach, and requirements of the program.
Patients who elect to enroll must sign a contract agreeing
to attend ≥80% of scheduled appointments. Those who fail
to comply are terminated from the program. Patients are
seen by a physician for an initial assessment, at one month,
and quarterly thereafter. Patients are seen and weighed
weekly by a dietitian during the first month, and monthly
thereafter. The entire 2-year program involves 11 visits with
a physician and 26 visits with a dietitian. Laboratory moni-
toring is performed at baseline prior to dietary intervention,
at one month during VLCD in patients at high risk for
metabolic derangements (e.g. chronic kidney disease, his-
tory of heart failure), and every 3 to 6 months thereafter
depending on the participant’s comorbid health conditions.
Over the first 3 to 6 months of the program, participants
consume a very low calorie diet (VLCD, 800 kcal/day) in
the form of total meal replacement and are asked to grad-
ually increase low to moderate intensity physical activity
to 40 minutes per day. They are also asked to keep diaries
to record the number of meal replacement shakes and
soups they consume, deviations from the prescribed diet,
feelings of hunger, satiety, and mood, and physical activity.
These diaries are reviewed each week with the dietitian
either in person, by telephone, or by email. Following
the initial 3 to 6 months, participants are transitioned to
regular food stuffs. An exercise physiologist is available
to provide a one-time, one-hour, exercise consultation
to develop an activity program that incorporates patient
preferences. Participants are subsequently asked to per-
form 40 to 90 minutes of moderate to vigorous physical
activity at least 4 days per week.
In this report, we analyzed data from participants
who enrolled in the WMP between January 1, 2010
and December 31, 2011. All program participants hadBMI ≥32 kg/m2 with one or more comorbidities or
BMI ≥35 kg/m2. The majority (96%) of participants were
insured by Healthy Blue Living (HBL), a commercial
health insurance plan that includes strong financial
incentives for patients, providers, and employers to
work towards improved health in six high-impact areas
including obesity [3]. The remainder had commercial
health insurance plans that covered the WMP but not
copayments for dietitian visits. All participants paid for
meal replacements which averaged $300/month. HBL
members who adhered to program requirements received
enhanced benefits: co-payments were waived for diet-
itian visits and were reduced for prescription drugs. All
participants who did not attend ≥80% of scheduled
appointments were terminated for non-adherence. HBL
members who were terminated reverted to standard
health insurance benefits. The difference in out-of-pockets
costs between HBL enhanced and standard benefits is
approximately $800 per participant per year.
We assessed health-related quality-of-life using the
EQ-5D, a 5-item generic health utility instrument in which
a summary score of 1.0 represents the best imaginable
health state and a score of 0 represents a health state
equivalent to death [4]. We also assessed health-related
quality-of-life with the Impact of Weight on Quality-of-
Life-Lite (IWQOL-lite), a 31-item, self-reported measure
of obesity-specific quality-of-life that is responsive to
weight loss and weigh gain [5]. For participants enrolled
after May 2010, we also assessed depressive symptom
severity with the Inventory of Depressive Symptomatology-
Self Report (IDS-SR), a 30-item instrument that provides a
total score ranging from 0 to 84 [6]. A score of 0 to 13
corresponds to no depressive symptoms and scores of 14 to
25, 26 to 38, 39 to 48, and 49 to 84 correspond to mild,
moderate, severe, and very severe depressive symptoms.
The demographic and clinical characteristics of the
study population were described using means ± standard
deviation (SD) or number and percentage (%). Partici-
pants who did not have any visits on or after 3, 6, 12, 18,
and 24 months were defined as having withdrawn at
each time point. Participants were divided into groups
according to the length of time they were enrolled in the
weight management program. Short-term completers
were defined as those who made at least one visit on or
after 6 months, and 2 year completers were defined as
those who made at least one visit 22 to 24 months after
enrollment. The demographic and clinical characteristics
of the study population stratified by short-term and 2-year
completion were compared using t-tests for continuous
variables and chi-square tests for categorical variables. A
multivariate logistic model was constructed to predict
2 year completion using variables that were significant
(p ≤0.1) in bivariate analyses (with the exception of
IDS-SR because of missing values). The model included
Table 1 Baseline characteristics of program participants*
Total N = 270





NonHispanic White 229 (85%)
Other 41 (15%)
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type (Healthy Blue Living vs. other), BMI (kg/m2), EQ-5D
score, EQ-5D anxiety or depression score (moderate or
severe vs. non), and IWQOL-lite score. In the model, age
in years, BMI (kg/m2), EQ-5D score, and IWQOL-lite
score were defined as continuous variables.
Analyses were performed using SAS version 9.3 (SAS
Institute, Cary, NC). The study was reviewed and approved
by the University of Michigan Institutional Review Board
and all participants provided written informed consent.Marital status (missing = 2)
Married or life partner 237 (88%)
Other 31 (12%)
Education (missing = 2)
High school or less 9 (3%)
Some college 48 (18%)
College graduate 116 (43%)
Professional degree 95 (35%)
Employment (missing = 5)
Employed 214 (81%)
Retired/keeping house/other 51 (19%)
Insurance group
Healthy Blue Living (HBL) 259 (96%)
Other 11 (4%)
Distance from home to clinic (km) (missing = 2) 35 ± 18
Body mass index (kg/m2) 41 ± 5




Obstructive sleep apnea 93 (34%)
Osteoarthritis 80 (30%)
Depression 57 (21%)
EQ-5D (missing = 3) 0.84 ± 0.13
Mobility problems 68 (25%)
Self-care problems 7 (3%)
Usual activities problems 64 (24%)
Pain problems 174 (65%)
Anxiety/depression problems 86 (32%)
IWQOL-lite** (missing = 3) 68 ± 18
IDS-SR*** (missing = 65) 14 ± 9
*Results are expressed as mean ± standard deviation or number (%).
**Impact of Weight on Quality-of-Life-Lite.
***Inventory of Depressive Symptomatology-Self Report.Results
Between January 1, 2010 and December 31, 2011, 300
participants enrolled in the University of Michigan Weight
Management Program (WMP). Thirty participants invol-
untarily withdrew before 2-years of follow-up: 25 because
of changes in health insurance, 3 because they moved out
of the area, 1 because of pregnancy, and 1 because of
death. These participants were not considered in this
report. Of the 270 enrollees who could have potentially
completed the program, 137 (51%) completed it and 133
(49%) failed to complete it. Of those who failed to
complete the program, 67 (50%) were terminated for non-
adherence, 40 (30%) stopped attending despite repeated
attempts to contact them, and 26 (20%) withdrew for
other reasons including 3 who elected to undergo bariatric
surgery.
Table 1 shows the baseline characteristics of the 270
program participants. Mean age was 49 ± 8 years, 48% were
men, and 85% were non-Hispanic whites. In general, the
population was married, highly educated, and employed.
Most (96%) had Healthy Blue Living (HBL) insurance,
which provided a financial incentive for program participa-
tion. The mean distance from home to the intervention site
was 35 ± 18 kilometers. Mean BMI was 41 ± 5 kg/m2 at
baseline and comorbidities were common. At baseline, 29%
had diabetes, 53% had hypertension, 50% had dyslipidemia,
34% had obstructive sleep apnea, 30% had osteoarthritis,
and 21% had depression. One-quarter to nearly two-thirds
of participants reported at least some problems with
mobility, usual activities, pain, and anxiety or depression.
Health-related quality-of-life as assessed by the EQ-5D
was generally good although depressive symptoms as
assessed by both the EQ-5D and the Inventory of Depres-
sive Symptomatology-Self Report (IDS-SR) were common
as was the negative impact of weight on health-related
quality-of-life as assessed by the IWQOL-lite.
Table 2 shows participant retention at 3, 6, 12, 18, and
24 months. In general, retention was excellent at 3 months
(90%) and 6 months (83%). Attrition was greatest between
6 and 12 months, after the transition from VLCD to regu-
lar food stuffs. Retention was 67% at 12 months, 55% at
18 months, and 51% at 2 years.Table 3 shows the baseline characteristics of partici-
pants who completed 6 or more months in the program
(n = 223) compared to those who were terminated or
withdrew before 6 months (n = 47), and those who
Table 2 Participant retention over time (n = 270)
Retained Withdrew*
At 3 months 244 (90%) 26 (10%)
At 6 months 223 (83%) 47 (17%)
At 12 months 181 (67%) 89 (33%)
At 18 months 149 (55%) 121 (45%)
At 24 months 137 (51%) 133 (49%)
Mean number of program visits attended 21 ± 2 10 ± 5
*Withdrawal defined as no visits on or after the month specified.
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those who were terminated or withdrew before 2 years
(n = 133). Participants who completed 6 months and
2 years in the program were significantly older and had
lower baseline BMIs compared to non-completers at
6 months and 2 years. Compared to 6 month non-
completers, participants who completed 6 months in the
program were more likely to be highly educated and
employed (p < 0.1). Participants who completed 2 yearsTable 3 Baseline characteristics of completers and noncomple
Short-term
completer* N = 223
Short-term
noncompleter N
Age (years) 50 ± 8 46 ± 9
Race/ethnicity
NonHispanic White 190 (85%) 39 (83%)
Other 33 (15%) 8 (17%)
Education (missing = 2)
High school or less 8 (4%) 1 (2%)
Some college 34 (15%) 14 (30%)
College graduate 102 (46%) 14 (30%)
Professional degree 78 (35%) 17 (37%)
Employment (missing = 5)
Employed 181 (83%) 33 (72%)
Retired/keeping house/other 38 (17%) 13 (28%)
Insurance group
Healthy Blue Living 215 (96%) 44 (94%)
Other 8 (4%) 3 (6%)
Body Mass Index (kg/m2) 40 ± 5 43 ± 7
EQ-5D (missing = 3) 0.84 ± 0.13 0.82 ± 0.14
Mobility limitations 58 (26%) 10 (21%)
Self-care limitations 7 (3%) 0
Usual activities 52 (24%) 12 (26%)
Pain 141 (64%) 33 (70%)
Anxiety/depression 69 (31%) 17 (36%)
IWQOL-lite** (missing = 3) 68 ± 17 64 ± 19
IDS-SR*** (missing = 65) 14 ± 9 17 ± 10
*Short-term completers defined as those with a visit at or after 6 months.
**Impact of Weight on Quality-of-Life-Lite.
***Inventory of Depressive Symptomatology-Self Report.in the program had fewer baseline problems with anxiety
and depression as assessed by the EQ-5D, and exhibited
less impact of both depressive symptoms and weight on
health-related quality-of-life (p < 0.05). Compared to 2-
year non-completers, participants who completed 2 years
in the program were more likely to be insured by HBL
which provided financial incentives for ongoing program
participation, to be non-Hispanic White, and to have
better baseline health-related quality-of-life as assessed
by the EQ-5D (p < 0.1). Sex, marital status, distance from
home to the intervention site, and baseline comorbidi-
ties were not associated with retention at either 6 months
or 2-years.
When factors associated with completing the 2-year
program (p ≤ 0.1) were entered into a multivariable logis-
tic regression model to predict retention, only three
factors were independently and significantly associated
with retention. These were older age, lower baseline BMI,
and having health insurance that provided financial incen-







0.0033 51 ± 8 47 ± 8 0.0002
0.6995 0.0490
122 (89%) 107 (80%)
15 (11%) 26 (20%)
0.0644 0.6864
4 (3%) 5 (4%)
24 (18%) 24 (18%)
64 (47%) 52 (40%)
45 (33%) 50 (38%)
0.0880 0.4907
106 (79%) 108 (83%)
28 (21%) 23 (18%)
0.4122 0.1119
134 (98%) 125 (94%)
3 (2%) 8 (6%)
0.0177 40 ± 5 42 ± 6 0.0015
0.3662 0.85 ± 0.12 0.82 ± 0.14 0.0745
0.4675 36 (27%) 32 (24%) 0.6494
0.6103 4 (3%) 3 (2%) 0.7242
0.7823 32 (24%) 32 (24%) 0.9179
0.4239 87 (64%) 87 (66%) 0.8017
0.5221 36 (27%) 50 (38%) 0.0500
0.1441 70 ± 17 65 ± 18 0.0138
0.0826 13 ± 9 16 ± 10 0.0331
Table 4 Factors independently associated with program retention at 2 years
Factor Wald chi-square p-value Odds ratio 95% wald confidence limits
Intercept 0.22 0.6358 – –
Older age (years) 10.31 0.0013 1.06 1.02-1.09
Other race 1.31 0.2516 0.65 0.31-1.36
Healthy Blue Living Insurance 4.51 0.0337 5.92 1.16-22.68
Higher BMI (kg/m2) 6.05 0.0139 0.93 0.87-0.99
Higher EQ-5D score 0.24 0.6221 1.87 0.16-22.68
Moderate or severe Anxiety/Depression (EQ-5D) 0.89 0.3459 0.72 0.37-1.42
Higher IWQOL-lite* 0.04 0.8514 1.00 0.98-1.02
*Impact of Weight on Quality-of-Life-Lite.
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depression as assessed by the EQ-5D were not independ-
ently associated with completing the 2-year program. In
sensitivity analyses, we included all variables in Table 3 in
three separate models, each including only one HRQOL
variable (EQ-5D score, moderate or extreme anxiety/
depression as assessed by the EQ-5D, or IWQOL-lite
score). The results were not different.
Figure 1 shows change in weight in kilograms over time
for program completers and non-completers. The percent
of baseline body weight lost at 6 months was signifi-
cantly associated with program retention at 6 months
(16.0 ± 7.3% vs. 9.3 ± 4.6%, p < 0.0049). The percent of
baseline body weight lost at 6 months was also associ-
ated with program retention at 2 years (17.7 ± 6.4% vs.
12.9 ± 7.8%, p < 0.0001).
Table 5 shows the changes in outcomes among par-
ticipants who completed the 2-year program. Weight
decreased by 15 ± 12 kg and BMI decreased by 5.1 ±
4.0 kg/m2. There were significant improvements in both
systolic blood pressure and HDL-cholesterol despite lessFigure 1 Change in weight (kg) over time for 2-year program
completers and noncompleters.frequent use of antihypertensive and lipid lowering med-
ications. Mean EQ-5D score improved by 0.06 ± 0.12. A
change greater than 0.03 is considered to be clinically
meaningful. Nineteen percent of participants who reported
at least some limitations in mobility, 2% who reported some
limitations in self-care, 22% who reported some limitations
in usual activity, 33% who reported some pain, and 13%
who reported some anxiety or depression at baseline
reported no limitations at follow-up 2-years later. Mean
IWQOL-lite scores increased by 15 ± 13: a 7.7 to 12 point
increase in the total score is considered to be a clinically
meaningful improvement. The impact of depressive
symptoms also decreased significantly between baseline
and follow-up and the mean number of antidepressant
medications prescribed increased significantly. Among
2-year program completers, 56% of those with diabetes
reported improvements at follow-up as did 23% of those
with hypertension, 13% of those with dyslipidemia, 27% of
those with obstructive sleep apnea, 4% of those with
osteoarthritis, and 52% of those with anxiety or depression
(as measured by the EQ-5D subscore).Table 5 Changes in outcomes among participants who
completed 2 years in the program (n = 137 unless
otherwise specified)
Change from baseline p-value
Weight (kg) −15 ± 12 <0.0001
Body mass index (kg/m2) −5.1 ± 4.0 <0.0001
Systolic blood pressure (mmHg) −5 ± 16 0.0002
HDL cholesterol (mg/dl) (n = 119) 11 ± 9 <0.0001
Mean number of medications
Blood pressure −0.34 <0.0001
Lipid lowering −0.09 0.0068
Depression 0.09 0.0011
EQ-5D (n = 87) 0.06 ± 0.12 <0.0001
IWQOL-lite* (n = 87) 15 ± 13 <0.0001
IDS-SR** (n = 70) −2.6 ± 7.0 0.0026
*Impact of Weight on Quality-of-Life-Lite.
**Inventory of Depressive Symptomatology-Self Report.
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In this study, we demonstrated both high retention and
excellent weight loss outcomes among moderately and
severely obese patients, many of whom met BMI criteria
that would potentially qualify them for bariatric surgery.
Instead, they enrolled in a 2-year, physician-led, multi-
disciplinary, weight management program that employed
meal replacement products to induce weight loss and
intensive behavioral interventions and financial incen-
tives to promote long-term weight loss maintenance.
Retention was 83% at 6 months and 51% at 2 years. The
greatest attrition occurred after the transition from VLCD
to regular food stuffs. Our results are encouraging in that
an analysis of data from the National Weight Control
Registry found that individuals who succeed in main-
taining their weight loss for 2 years reduce their risk of
subsequent weight regain by nearly 50% [7].
Older age at enrollment, lower baseline BMI, and having
health insurance that provided a financial incentive for
program participation were independently associated
with 2-year program retention. Many investigators have
reported that older individuals are more likely to adhere
to behavioral weight management and intensive life-
style interventions, perhaps because of fewer competing
demands [2,8,9]. Our finding that lower baseline BMI
was associated with program retention differs from the
findings of other studies [2] and does not appear to be
explained by differences in the prevalence of functional
limitations or comorbidities. It should be recognized,
however, that at baseline, 89% of our study participants
were at least moderately obese (BMI 35-39.9 kg/m2)
and 47% were severely obese (BMI ≥ 40 kg/m2). Martin
et al have previously demonstrated that retention in a
commercial weight loss program was higher when par-
ticipation was promoted through incentives and when
participants enrolled through their work even when
they paid out-of-pocket for the program [10]. Our finding
that the behavioral economic approach of loss aversion,
which takes away an existing benefit when an individual
fails to achieve a health goal rather than rewarding an
individual for achieving the health goal, improved pro-
gram uptake and retention and should be tested in other
settings [3].
The rate of weight loss over the first 6 months of
program participation was greater for 2-year program
completers than non-completers, and program completers
lost a significantly greater percentage of baseline body
weight at both 6 months and 2 years. Indeed, we found
that the percent change in body weight as early as 2 weeks
after program initiation predicted percent change in body
weight at 12 weeks (data not shown). Fabricatore and
colleagues and Wadden and colleagues have also reported
that early weight loss predicts longer-term weight loss
success in the setting of randomized, controlled clinicaltrials [9,11]. For those who completed our 2 year program,
mean weight loss was 15 ± 12 kilograms and mean reduc-
tion in BMI was 5.1 ± 4.0 kg/m2. There were substantial
improvements in cardiovascular risk factors, comorbi-
dities, and health-related quality-of-life among program
completers.
Our results differ from those of Tsai and Wadden [1]
and Spring and colleagues [2] who reported lesser degrees
of initial weight loss, lower patient retention, and greater
weight regain among participants enrolled in behavioral
weight management programs. The differences in initial
weight loss may be explained in part by differences in
program structure. Wing et al reported that people who
were provided behavioral therapy and an additional
modality (e.g. a shopping list or the direct provision of
food) did better than those who were provided behavioral
therapy alone [7]. Diets that incorporate meal replace-
ments result in predictable weight loss by divorcing
patients from unhealthy habits and by making their meals
decision-free. Lichtman et al examined reported energy
intake, actual energy intake, and total energy expenditure
during a 14-day study [12]. Substantial differences were
observed between reported and actual energy intake (a
mean of >1,000 kcal/day). Failure to lose weight with diet
was explained by underestimation and under-reporting of
caloric intake and not by low energy expenditure. Indeed,
no subject had a total energy expenditure or resting meta-
bolic rate more than 10% below his or her predicted value.
Use of meal replacement products provides structure,
removes the need to make decisions about food choices,
and results in a more predictable number of calories con-
sumed and more predictable reductions in weight.
Although freedom from depression and from depres-
sive symptoms did not predict retention in our clinical
program at 2 years, our results related to depression
warrant further discussion. In univariate analyses, two-
year completers were significantly less likely to report
moderate or severe anxiety or depression at baseline and
reported fewer depressive symptoms on the IDS-SR than
noncompleters. In addition, IDS-SR scores were signifi-
cantly improved from baseline among participants who
completed 2 years in the program in the context of more
frequent antidepressant medication use. In a review of
psychosocial predictors of weight control, Teixeira and
colleagues found that depression, when assessed before
treatment, did not predict treatment outcomes [13]. Fab-
ricatore and colleagues have shown that in a clinical trial
setting, fewer depressive symptoms at baseline predict
weight loss success at one year [9]. Elder and colleagues
have demonstrated a strong correlation between weight
loss and reduction in depression [14] and Wing and
Phelan have demonstrated that lower levels of depression
are related to greater odds of weight loss maintenance
[7]. These results suggest that identifying and treating
Rothberg et al. BMC Obesity  (2015) 2:11 Page 7 of 7depression, especially during and immediately after the
transition from VLCD to regular food stuffs, may be an
important determinant of weight loss maintenance and
program retention.
Conclusion
In summary, we have demonstrated that a physician-led,
multidisciplinary, clinical, weight management program
that employs short-term meal replacement for weight loss
induction and intensive behavioral therapy and financial
incentives for longer-term weight loss maintenance demon-
strated both high retention and excellent outcomes. Older
participants and those with moderate as compared to se-
vere obesity were more likely to complete the 2-year clinical
program. Participants with less anxiety and depression and
less severe symptoms of depression also tended to be more
likely to complete the 2-year program although the results
were not statistically significant in multivariate analysis.
Future interventions should further explore the relationship
between depression and program retention.
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